Health Care·Life Sciences Tools & Services·$174.6B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $7.09 | N/A | +3.32% |
management commentary, guidance changes, and full analysis available with Pro.
| +3.32% |
Tone: Cautiously Optimistic
Management expressed satisfaction with the earnings performance, highlighting strong demand for their offerings. They emphasized their commitment to innovation despite ongoing challenges.
We are pleased with our performance this quarter, reflecting strong demand for our products.
Our focus remains on innovation and meeting customer needs in a challenging environment.
Thermo Fisher Scientific's strong EPS performance indicates resilience in their business, particularly amid ongoing market challenges. The stock's 1.13% increase reflects investor confidence in the company's ability to maintain growth. However, the lack of revenue data and guidance may leave some investors cautious about future performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
SAP SE ADR
Jan 29, 2021